KALEIGH MARIE STEPHENSON

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family MINDEN, LA NPI 1336764604

General Payments — all program years on this page

$1,182.64

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 64
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $377.89 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $377.8920

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $242.4912
2022 $208.7113
2023 $353.5519
2024 $377.8920

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086293756 Bayer Healthcare Pharmaceuticals Inc. $17.74 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086309393 Bayer Healthcare Pharmaceuticals Inc. $17.99 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086358970 Bayer Healthcare Pharmaceuticals Inc. $17.78 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087198999 Novartis Pharmaceuticals Corporation $13.36 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087199001 Novartis Pharmaceuticals Corporation $15.47 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104319866 AstraZeneca Pharmaceuticals LP $18.73 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104700861 AstraZeneca Pharmaceuticals LP $19.59 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113934526 Paratek Pharmaceuticals, Inc. $13.09 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126071022 HARMONY BIOSCIENCES LLC $30.26 06/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126071024 HARMONY BIOSCIENCES LLC $27.95 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126071026 HARMONY BIOSCIENCES LLC $22.46 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126071028 HARMONY BIOSCIENCES LLC $21.16 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131778928 PFIZER INC. $15.49 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139461408 Astellas Pharma US Inc $16.47 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139512373 Astellas Pharma US Inc $13.17 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141985539 Merck Sharp & Dohme LLC $14.56 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144572225 Indivior Inc. $22.64 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144630295 Xeris Pharmaceuticals, Inc. $14.46 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147305119 Mylan Specialty L.P. $23.56 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151207903 Phathom Pharmaceuticals, Inc. $21.96 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.